News

When ED Tablets Do Not Help: A New Review Maps Next Steps

A review in the November 2026 issue of Current Opinion in Urology argues for a structured reassessment when an ED tablet does not help. The authors describe several reasons for an apparent treatment failure and distinguish them from a persistent problem that calls for another approach.

One Unsuccessful Attempt Does Not Define the Problem

The review covers men who do not respond adequately to phosphodiesterase type 5 inhibitors. It identifies patient education, psychological support, lifestyle changes, and treatment of associated conditions as parts of care that can affect response. The authors also discuss hormone treatment in men with confirmed hypogonadism and established alternatives for persistent ED.

This is a review of existing evidence, not a new randomized trial proving one rescue treatment. Its central clinical question is whether the first treatment received a fair trial and, if it did, which next step fits the man's needs and preferences.

Reconstruct What Actually Happened

A medication review should cover the name of the medicine, prescribed instructions, timing, food and alcohol, sexual stimulation, and what happened during the attempt. The AUA guideline recommends giving men instructions intended to obtain the greatest benefit and reviewing dose selection within the prescribing plan.

A patient may mean that he could not develop an erection, lost it too early, disliked an adverse effect, or never felt enough arousal to try. Those experiences call for different questions. Bring the packaging or prescription details when possible. Describing the attempt usually gives the clinician more useful information than saying that a particular brand never works.

Check for a Change in Health or Circumstances

NIDDK describes treatment of underlying conditions, counseling where appropriate, and review of medicines as parts of ED care. A drug prescribed for another condition can contribute to symptoms, but a patient should not stop it without discussing the issue with the treating clinician. Anxiety and relationship strain may also need attention alongside a physical assessment.

A follow-up therefore needs more than a request for a stronger tablet. Explain whether the problem started recently, has progressed, or now occurs in situations where erections previously worked well. Discuss new diagnoses, surgery, sleep changes, stress, and prescriptions. The clinician can then decide whether the original assessment needs an update.

Testosterone Has a Defined Role

The Fifth International Consultation on Sexual Medicine recommendations discuss testosterone replacement for men who have both ED and testosterone deficiency, particularly when PDE5 inhibitors have not produced an adequate response. That recommendation concerns a confirmed deficiency; it does not support adding hormone treatment to every unsuccessful ED prescription.

Ask what evidence supports a hormone contribution in your case and which measurements would confirm it. If the clinician recommends treatment, agree on the symptom target and follow-up. An erection problem and a low laboratory value may need a connected plan, but they should not become a reason to bypass diagnosis or monitoring.

Alternatives Remain Part of the Discussion

The consultation recommendations include vacuum erection devices, injections, and penile prostheses for men who cannot use, tolerate, or benefit from PDE5 inhibitors. Each option places different demands on the patient and has its own risks. A clinician can explain how it works, what preparation or training it needs, and how it may fit partnered sex.

The November review also discusses emerging and combination approaches. Some have limited evidence or need specialist supervision. A review's discussion of a possibility does not establish it as routine care. Do not combine two ED tablets or add another treatment without a prescriber's instructions.

Describe Benefit as Well as Failure

A partial response can tell a clinician something different from no response. Explain whether firmness improved, whether it lasted longer, or whether the medicine helped only in some situations. Also describe any practical reason you stopped using it. Cost, preparation, adverse effects, and expectations can each change the next decision.

Ask the clinician to name what the next trial will test. It might clarify correct use, compare a different prescribed approach, or determine whether another treatment fits better. A follow-up works best when both patient and prescriber know which change they intend to evaluate.

A Follow-up Plan Should Specify the Next Decision

Ask how long to try the agreed approach, what response to record, and which adverse effects require contact. Decide when to return and what would prompt a change. If practical issues prevent using the treatment, raise them directly rather than continuing a prescription that you cannot use.

It may help to bring your partner if you want their input. Discuss spontaneity, comfort, privacy, and the amount of preparation you can accept. Those preferences can change which treatment offers the best fit even when several options could produce an erection.

Our ED treatment overview covers prescription medicines and procedures. The implant information page provides background for patients who want to discuss that option after an assessment.

Sources

Comments

Leave a comment